Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450351 | PMC |
http://dx.doi.org/10.2215/CJN.02350219 | DOI Listing |
J Diabetes Complications
December 2024
Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland; Tampere University Hospital, Department of Internal Medicine, Tampere, Finland.
Aims: To assess the effect of comorbidities, risk classification for chronic kidney disease (CKD) according to albuminuria and eGFR, HbA1c and LDL-cholesterol levels on all-cause mortality in patients with type 1 diabetes (DM1).
Methods: The study included all 45,801 DM1 patients from the Finnish Diabetes Registry during 2018-2022. Mortality of patients with DM1 was compared with mortality in non-diabetic population in Finland by estimating standardized mortality rates (SMRs).
J Health Popul Nutr
August 2024
Hubert Department of Global Health, Rollins School of Public Health, Emory University, Georgia, Atlanta, USA.
Background: Non-communicable diseases (NCDs) pose a significant global health challenge, constituting over 80% of mortality and morbidity. This burden is particularly pronounced in low- and middle-income countries (LMICs), including Ethiopia. Despite this, there's limited research on this issue in Africa.
View Article and Find Full Text PDFIntroduction Renal failure, comprising acute kidney injury (AKI) and chronic kidney disease (CKD), involves a decline or loss of kidney function. AKI is sudden and reversible, with a rapid decline in function over hours to days, while CKD involves persistent abnormalities lasting at least three months. Developing countries are seeing a rise in AKI cases, especially in critically ill patients.
View Article and Find Full Text PDFBMC Nephrol
April 2024
Section of Endocrinology and Metabolism, Department of Internal Medicine, Ditmanson Medical Foundation, Chiayi Christian Hospital, No. 539 Jhongsiao Rd., Chia-Yi City, 600, Taiwan R.O.C..
Clin Kidney J
January 2024
Renal Research Institute, New York, USA, Institute of Biology and Molecular Biology (BIOGEM), Ariano Irpino, Italy and IPNET, Reggio Calabria, Italy.
Meta-analyses offer an estimate of the overall effect size and help address the inconsistency in findings across studies. The risk is the overemphasis on statistical significance while underrepresenting or misinterpreting clinical significance. There's also a lack of standardized methods for quantifying and reporting clinical significance and these measures are often missing or inconsistently reported in many meta-analyses, making it difficult for readers to determine the clinical relevance of the findings.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!